Search
Search Results
##search.searchResults.foundPlural##
-
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1358PDF: 512HTML: 432 -
-
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2074PDF: 114HTML: 30 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3824PDF: 1517HTML: 329 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1562PDF: 938HTML: 2251Response to reviewers comments: 202 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
878PDF: 493HTML: 1310 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2222PDF: 844HTML: 443 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9276PDF: 6179HTML: 88043Fig.1b: 210Fig.1c: 216Fig.2a: 201Fig.2b: 195Fig.4: 222Fig.2c: 200Fig.3: 202Tab.1: 254Tab.2: 233Tab.3: 213Tab.4: 248Fig1a: 210 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2656PDF: 903HTML: 17592Fig1 Caligaris: 196Fig.2 Caliga: 240 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1934PDF: 1194HTML: 336 -
-
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1177PDF: 530HTML: 382 -
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1345PDF: 617HTML: 1113 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2754PDF: 977HTML: 627 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1350PDF: 897HTML: 1198Coverletter: 229 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
942PDF: 690Suppl. Files: 140HTML: 139 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1332PDF: 1104HTML: 245 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3466PDF: 1321HTML: 2308Fi.1 Gritti.Rambaldi: 224 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2277PDF: 1000HTML: 1980 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1344PDF: 612HTML: 3955 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
550PDF: 275HTML: 107 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
759PDF: 478HTML: 6277 -
-
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2318PDF: 927HTML: 2204 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2668PDF: 892HTML: 2130 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1433PDF: 833HTML: 1027 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
223PDF: 341Suppl. Files: 59HTML: 114 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2202PDF: 610HTML: 1166







